Companies related to Neurodegeneration

A techbio platform company developing AI & microfluidics-based in vivo, in vitro & protein characterization solutions.

Voted Best Tech Start-up in North America (2022 Timmy Awards)

The new Italian research institute for Life Sciences based at the heart of MIND - Milano Innovation District.

Harnessing the collective genius of science and breaking free of established dogma to promote brain resiliency.

Laying the foundations for tomorrow's medicine

Brain.Research.Life

Committed to change the fate of age-related neurodegenerative diseases

Üsküdar University, cellular therapies and stem cell production, application and research center.

We support ambitious scientists of any nationality, driven by passion to pursue frontier research.

Defeat Degeneration

Helping brain researchers decipher the awake brain

AI Software Dementia Screening

Pioneering therapies for people with neurological disorders

Developing a New Class of Molecular Diagnostics and Digital Biomarkers for the Eye to Diagnose & Monitor Human Diseases

Creating a new path for neurodegenerative diseases

#IRBM — powerful integrated drug discovery from concept to candidate.

Pioneering personalized medicine in epigenetics

Developing a new class of therapeutics for neurodegenerative and psychiatric diseases

Treating Neurodegenerative Disease by Restoring Autophagy

Macrophage Biology Revealed:Developing breakthrough approaches to macrophage activity to change the course of disease

Drug discovery for neurodegenerative diseases

Developing first and best-in-class neuroplastogens for diseases where neuronal connectivity is altered

Neuro-Bio is a privately-owned biotech out of Oxford University with a therapeutic focus on neurodegenerative diseases.

Advancing knowledge of human development, developmental disabilities, and neurodegenerative diseases.

Pioneering next-gen therapeutics to treat inflammation-driven neurodegenerative diseases and autoimmune disorders.

AI-driven psychedelic drug discovery

Fighting Alzheimer’s by Restoring the Brain’s Innate Clearance Systems

A purpose driven biotechnology company committed to responsible research, development, and innovation.

A global leader in bispecific antibody therapeutics for immuno-oncology and neurodegenerative diseases.

Smarter Molecules, Targeted Delivery, Faster to Patients.

Unlock biomedical research data with comprehensive bioinformatics